"Jenex received a Class II medical device status from the FDA for its platform technology that is indicated for the relief of the pain, itch, and inflammation from over 20,000 different insect stings and bites, (including bees, wasps, hornets, mosquitoes, black flies and jellyfish). Jenex received approval for the above claims from FDA (United States) in 1997"
"Luminar Media Group, Inc., (Luminar, OTCMKTS: $LRGR) and The Jenex Corporation (Jenex, NEX: $JEN.H) report the completion of a working prototype for the patent pending TherOZap™ device. An Agreement has been signed with the University Health Network to test Therozap™ against the Zika and West Nile viruses. " http://finance.yahoo.com/news/luminar-media-group-inc-university-132000474.html